2013
DOI: 10.1152/ajpcell.00023.2013
|View full text |Cite
|
Sign up to set email alerts
|

CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis

Abstract: Basuroy S, Leffler CW, Parfenova H. CORM-A1 prevents bloodbrain barrier dysfunction caused by ionotropic glutamate receptormediated endothelial oxidative stress and apoptosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
39
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 49 publications
(42 citation statements)
references
References 48 publications
2
39
1
Order By: Relevance
“…Rat brain endothelial cells, astrocytes and pericytes were treated with kainate (213 Da; 100 mM stock solution was prepared in sterile water by the addition of NaOH) at 10 µM and 100 µM concentrations in culture medium for 1 and 24 h, based on our preliminary experiment and in agreement with literature data [32]. Simvastatin, edaravone (for both 1 mM stock solution was prepared in dimethyl sulfoxide) and dexamethasone (cyclodextrin complex; 10 mM stock solution was prepared in sterile water) were applied at a concentration of 1 µM based on our preliminary study and literature data [21,23,25].…”
Section: Treatmentsmentioning
confidence: 70%
See 1 more Smart Citation
“…Rat brain endothelial cells, astrocytes and pericytes were treated with kainate (213 Da; 100 mM stock solution was prepared in sterile water by the addition of NaOH) at 10 µM and 100 µM concentrations in culture medium for 1 and 24 h, based on our preliminary experiment and in agreement with literature data [32]. Simvastatin, edaravone (for both 1 mM stock solution was prepared in dimethyl sulfoxide) and dexamethasone (cyclodextrin complex; 10 mM stock solution was prepared in sterile water) were applied at a concentration of 1 µM based on our preliminary study and literature data [21,23,25].…”
Section: Treatmentsmentioning
confidence: 70%
“…Excitotoxicity is one of the main pathological pathways in CNS diseases leading to both neuronal injury and BBB dysfunction [5,42]. Glutamate was shown to increase BBB permeability and reduce the integrity of tight junctions in culture models of the BBB [8,32,43]. Ionotropic glutamate receptor agonists NMDA and AMPA were also described to decrease resistance and increase permeability of porcine brain endothelial cells [32].…”
Section: Discussionmentioning
confidence: 99%
“…The strongest area of development in terms of understanding potential roles for these receptors is in the area of blood-brain barrier (BBB) function. While uncontrolled glutamate levels in brain are toxic to neurons, they are also likely to damage endothelial function and disrupt BBB integrity [20, 66,67]. There are indications that these endothelial effects are mediated by NMDARs and are related to altered expression of efflux transporters [68] and to reduced expression and redistribution of tight junction proteins [20], culminating in dramatically impaired barrier integrity [18] and transmigration of immune cells into the brain [31].…”
Section: Nmdars In Brain Endothelial Cell Physiologymentioning
confidence: 99%
“…So in the context of stroke and brain injury, excitotoxicity mechanisms should operate in multiple cell types. Besides astrocytes and oligodendrocytes, glutamate transporters also exist in pericytes [35], and over-activation of ionotropic glutamate channels can trigger apoptosis in cerebral endothelium as well [36, 37]. Excitotoxic cascades are not only a neuronal phenomenon but comprise all compartments in the neurovascular unit.…”
Section: Excitotoxicitymentioning
confidence: 99%